Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05064332 · ClinicalTrials.gov registry record · Phase 1
A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT05064332 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 10 participants.
The verdict
NCT05064332, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a Phase 1, open label, fixed sequence study of the effect of multiple dose PF-06650833 on single dose OC PK in healthy female subjects.
Interventions
- DRUG Ethinyl estradiol (EE) and levonogestrel (LN)
- DRUG PF-06650833
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-10-08 |
| Est. Completion | 2021-12-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05064332
The ClinicalTrials.gov registry entry for NCT05064332 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ethinyl estradiol (EE) and levonogestrel (LN) is the first listed.
NCT05064332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05064332 about?
NCT05064332 is a clinical study titled "A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)". This is a Phase 1, open label, fixed sequence study of the effect of multiple dose PF-06650833 on single dose OC PK in healthy female subjects.
What is the current status of trial NCT05064332?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2021-10-08. Estimated completion is 2021-12-16.
What interventions are being tested in trial NCT05064332?
The interventions under investigation include: Ethinyl estradiol (EE) and levonogestrel (LN) (DRUG), PF-06650833 (DRUG).
Who is sponsoring clinical trial NCT05064332?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.